208
Participants
Start Date
July 27, 2021
Primary Completion Date
October 19, 2027
Study Completion Date
October 19, 2027
Iptacopan
Taken orally b.i.d. Dosage supplied: 200 mg Dosage form: hard gelatin capsule Route of administration: oral
Novartis Investigative Site, Hualien City
Novartis Investigative Site, Taipei
Novartis Investigative Site, Torino
Montefiore Medical Center, The Bronx
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Donostia / San Sebastian
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Prisma Health Upstate, Greenville
Augusta University, Augusta
Novartis Investigative Site, Toulouse
Lakes Research, Miami Lakes
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Bassano del Grappa
Novartis Investigative Site, Nantes
Cleveland Clinic Foundation, Cleveland
Novartis Investigative Site, Essen
Novartis Investigative Site, Florence
Novartis Investigative Site, Aachen
Novartis Investigative Site, Lille
Novartis Investigative Site, Ascoli Piceno
Novartis Investigative Site, Paris
Novartis Investigative Site, Avellino
Novartis Investigative Site, Kota Kinabalu
Novartis Investigative Site, Ulm
USC Norris Cancer Center, Los Angeles
City Of Hope, Duarte
Univ of California Irvine (Chao Family Comprehensive Cancer Center), Orange
Novartis Investigative Site, Kuching
Novartis Investigative Site, Beijing
Novartis Investigative Site, Singapore
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Santo André
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Ostrava
Novartis Investigative Site, Brno Bohunice
Novartis Investigative Site, Nice
Novartis Investigative Site, Dresden
Novartis Investigative Site, Riesa
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Fukushima
Novartis Investigative Site, Kanazawa
Novartis Investigative Site, Isehara
Novartis Investigative Site, Suwa
Novartis Investigative Site, Suita
Novartis Investigative Site, Shinjuku Ku
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Niigata
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Leeds
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY